Individuals with asthma had an increased risk of developing atrial fibrillation (AF) than asthma-free individuals, with those who had active or uncontrolled asthma having the highest risk, according to the HUNT* study.
Reduced-dose dabigatran and rivaroxaban deliver better all-cause and cardiovascular mortality improvements than warfarin in elderly adults with atrial fibrillation (AF), according to a recent Taiwan study.
Elevated levels of the free thyroid hormone T3 (fT3) and a higher fT3/fT4 ratio in early pregnancy may point to a greater risk of developing gestational diabetes (GDM), according to a recent US-based study.
Use of potassium citrate (Kcit) and thiazide diuretics among stone-formers is associated with better health-related quality of life (HRQOL) without increasing the risk of gastrointestinal events, fatigue or sexual complaints, a study reports.
In patients with atrial fibrillation (AF), treatment with direct oral anticoagulants (DOACs) appear to reduce the risk of intracranial haemorrhage (ICH) and all-cause mortality in women only, a recent study has found. Additionally, the association of lower ICH risk persists when compared with warfarin users with good anticoagulation control.
The success of an intensive stunting recovery programme is negatively affected by late admission to the centre and the environmental conditions in which the children live in their households, according to a Brazil study.
Variations in albuminuria predict changes in renal risk among patients with hypertension and type 2 diabetes (T2D) under real-life clinical conditions, reports a study, suggesting that albuminuria status may help optimize therapeutic strategy.
A dual-hormone artificial pancreas (DAP) with a rapid delivery of insulin and pramlintide in a fixed ratio improves glycaemic control and reduces glucose variability in adults with type 1 diabetes (T1D) compared with first-generation artificial pancreas delivering insulin alone, according to a study presented at ADA 2018.
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.